Medicure (MCUJF) Income from Non-Controlling Interests (2017)
Medicure (MCUJF) recorded quarterly Income from Non-Controlling Interests of $5.7 million in Q4 2017, up 354.77% quarter-over-quarter from $1.2 million in Q3 2017.
Medicure (MCUJF) Income from Non-Controlling Interests (2017) Analysis & Trends
Medicure's Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $5.7 million for Q4 2017.
- In Q4 2017, Income from Non-Controlling Interests changed N/A year-over-year to $5.7 million; the TTM figure through Dec 2017 stood at $9.0 million (changed N/A YoY), while the FY2017 annual figure was $5.6 million, up 1299.87% from the prior year.
- Income from Non-Controlling Interests was $5.7 million for Q4 2017 at Medicure, up from $1.2 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $5.7 million in Q4 2017 to a low of $893606.3 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Medicure | - | - | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 5.68 Mn |
| Sep 30, 2017 | 1.25 Mn |
| Jun 30, 2017 | 1.14 Mn |
| Mar 31, 2017 | 893,606.31 |